Gili, Leo

Memorial Sloan Kettering Cancer Center

1 paper on CoChatORCID 0009-0007-5648-2722

Most cited papers

Verified
RRAS and RRAS2 mutations are recurrent oncogenic drivers in lung cancer and are sensitive to the pan-RAS inhibitor RMC-6236
Pfeil, A. J., Zhang, T., Cheng, R., Mattar, M. S., Gomez Marti, J. L., Gili, L., Lai, R., Khodos, I., Master, R. P., Dix, J.-M., et al. (2025) · Clinical Cancer Research
Lung Cancer Treatments and MutationsProtein Kinase Regulation and GTPase Signaling
Cited by 3

Go further with a free account

Verify every reference, keep papers in a library, and ask questions across them.

Sign up - it is free